drugset / Trial / NCT00863213

Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation

NCT00863213

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effectivity and safety of atrial fibrillation ablation, in comparison to antiarrhythmic drug therapy in patients with refractory, persistent atrial fibrillation.

Timeline

Start
2009-03
Primary completion
2011-03
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amiodarone Small molecule
Comparator Diltiazem Small molecule
Comparator flecainide Small molecule

Indications